Investigating the role of Miglustat in the management of a patient with Tangier’s Disease: a single case experiment.
MUSTANG is an n-of-1 trial of ABAB design which aims to determine, in a single patient, the efficacy of Miglustat to improve cholesterol metabolism and resulting neuropathy caused by Tangier disease.
Primary Objective
·?????? To determine the efficacy of Miglustat to improve arm fine motor control, finger dexterity and grip strength.
Secondary Objective
·?????? To determine the efficacy of Miglustat to improve Quality of Life, activities of daily living, aerobic capacity, endurance, ambulation and nerve conduction.
Mechanistic Objective
·?????? To investigate the potential mechanisms by which Miglustat does, or does not, have an effect.
This is an n-of-1 study of ABAB design, with alternating periods of intervention and control.
In progress, closed to recruitment.
A single patient with Tangier disease, who is already known to the chief investigator, and keen to try the intervention.
This trial is funded by a National Institute for Health and Care Research grant (award reference no. NIHR132844)
Senior Trial Manager:
Frances Webley
Trial Coordinator:
Tom Oliver
Email: mustang@soton.ac.uk
Email: ctu@soton.ac.uk
Esstential Trial Documents
MUSTANG Protocol v3 03-Mar-2022
MUSTANG GP Letter v1 11-Dec-2020
MUSTANG Consent Form v3 03-Mar-2022
MUSTANG Dietary Diary v1 21-Jan 2021
MUSTANG Overall Neuropathy Limitations Scale v2 05-Mar-2021
MUSTANG EQ-5D-5L Paper Self-Complete v1.2
MUSTANG EQ-5D-5L Paper Interviewer Administration v1.4
MUSTANG Pregnant Partner PIS v0.3 12-Aug-2021
MUSTANG Pregnant Partner consent form v0.1 19-May-2021
ISF Documents
MUSTANG -Instructions for Adverse and Serious Adverse Event Reporting v1 09-Mar-2021
MUSTANG - SAE-SUSAR Report Form v1 09-Mar-2021
MUSTANG - Adverse Event Form v1 11-Mar-2021
MUSTANG - Master Patient List v1 26-Nov-2020
MUSTANG - Pre-Visit Checklists v1 16-Feb-2021
MUSTANG - Site Visit Log v1 04-Jan-2021
MUSTANG - Study Contacts and Information Page v1 27-Nov-2020
IMP Documents
MUSTANG - Pharmacy Manual v1 20-May-2021
MUSTANG - Drug Accountability Log v2 01-Apr-2021
MUSTANG - Summary of Product Characteristics (SmPC) 18-Nov 202
Laboratory Documents
MUSTANG - Laboratory Manual v3 20-Apr-2021
MUSTANG - Plasma Sample Storage Log v1 24-Feb-2021
MUSTANG - Urine Sample Storage Log v1 12-Mar-2021
MUSTANG - Sample Shipment Log - Dried Blood Sport Filtercard v1 25-Feb-2021
MUSTANG - Sample Shipment Log - EDTA 10ml v1 04-Mar-2021
MUSTANG - Sampling Worksheet - EDTA 10ml for Platt Lab
MUSTANG - Sampling Worksheet - Li-heparin (6ml), Random Urine (5ml) for GOH
MUSTANG - Willink Referral Form 1
Case Report Forms
MUSTANG - Trial Registration Form v1 09-Feb-2021
MUSTANG - End of Study CRF v2 31-Mar-2021
MUSTANG - Pregnancy Report Form v1 31-Mar-2021
MUSTANG - CRF 01 Eligibility, Registration and Baseline v2 31-Mar-2021
MUSTANG - CRF 02 Patient Contact Details v2 31-Mar-2021
MUSTANG - CRF 03 Concomitant Medications v2 31-Mar-2021
MUSTANG - CRF 04 Medical History v2 31-Mar-2021
MUSTANG - CRF 05 Month 2, v2 31-Mar-2021
MUSTANG - CRF 06 Month 4, v2 31-Mar-2021
MUSTANG - CRF 07 Month 6, v2 31-Mar-2021
MUSTANG - CRF 08 Month 8, v2 31-Mar-2021
MUSTANG - CRF 09 Month 10, v2 31-Mar-2021
MUSTANG - CRF 10 Month 12, v2 31-Mar-2021
MUSTANG - CRF 11 Month 14, v2 31-Mar-2021
MUSTANG - CRF 12 Month 16, v2 31-Mar-2021
MUSTANG - CRF 13 Month 18, v2 31-Mar-2021
MUSTANG - CRF 14 Month 20, v2 31-Mar-2021
MUSTANG - CRF 15 Month 22, v2 31-Mar-2021
MUSTANG - CRF 16 Month 24, v2 31-Mar-2021